| MeSH term | MeSH ID | Detail |
|---|---|---|
| Abnormalities, Multiple | D000015 | 13 associated lipids |
| Abnormalities, Drug-Induced | D000014 | 10 associated lipids |
erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Andrews JI et al. | Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. | 2000 | Am. J. Obstet. Gynecol. | pmid:11035326 |
| Mercer BM et al. | Prenatal screening for group B Streptococcus. I. Impact of antepartum screening on antenatal prophylaxis and intrapartum care. | 1995 | Am. J. Obstet. Gynecol. | pmid:7573254 |
| Morales WJ et al. | Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. | 1999 | Am. J. Obstet. Gynecol. | pmid:10454674 |
| Campbell WF and Dodson MG | Clindamycin therapy for Chlamydia trachomatis in women. | 1990 | Am. J. Obstet. Gynecol. | pmid:2178426 |
| Quinn PA et al. | Efficacy of antibiotic therapy in preventing spontaneous pregnancy loss among couples colonized with genital mycoplasmas. | 1983 | Am. J. Obstet. Gynecol. | pmid:6849358 |
| Kemp MW et al. | Repeated maternal intramuscular or intraamniotic erythromycin incompletely resolves intrauterine Ureaplasma parvum infection in a sheep model of pregnancy. | 2014 | Am. J. Obstet. Gynecol. | pmid:24589547 |
| Jones RB | New treatments for Chlamydia trachomatis. | 1991 | Am. J. Obstet. Gynecol. | pmid:2039033 |
| Yost NP et al. | An appraisal of treatment guidelines for antepartum community-acquired pneumonia. | 2000 | Am. J. Obstet. Gynecol. | pmid:10920320 |
| Lin KJ et al. | Safety of macrolides during pregnancy. | 2013 | Am. J. Obstet. Gynecol. | pmid:23254249 |
| Croak A et al. | Predominance of serotype V and frequency of erythromycin resistance in Streptococcus agalactiae in Ohio. | 2003 | Am. J. Obstet. Gynecol. | pmid:12748459 |
| Milwidsky A et al. | Direct inhibition of proteases and cervical plasminogen activator by antibiotics. | 1992 | Am. J. Obstet. Gynecol. | pmid:1536241 |
| Johnson RB | The role of azalide antibiotics in the treatment of Chlamydia. | 1991 | Am. J. Obstet. Gynecol. | pmid:1645503 |
| Romero R et al. | Eradication of Ureaplasma urealyticum from the amniotic fluid with transplacental antibiotic treatment. | 1992 | Am. J. Obstet. Gynecol. | pmid:1536243 |
| Danielian P | Erythromycin, motilin, and meconium. | 1992 | Am. J. Obstet. Gynecol. | pmid:1536263 |
| Kundsin RB et al. | Ureaplasma urealyticum resistance to erythromycin: confirmed by clinical trial. | 1992 | Am. J. Obstet. Gynecol. | pmid:1615998 |
| Rao KV and Ralston RA | Meningitis due to Campylobacter fetus intestinalis in a kidney transplant recipient. A case report. | 1987 | Am. J. Nephrol. | pmid:3324765 |
| SOLOMON S and JOHNSTON B | The clinical use of erythromycin. | 1955 | Am. J. Med. Sci. | pmid:13268445 |
| Kislak JW et al. | Susceptibility of pneumococci to nine antibiotics. | 1965 | Am. J. Med. Sci. | pmid:4378532 |
| Kayser FH and Mak TM | Methicillin-resistant staphylococci. | 1972 | Am. J. Med. Sci. | pmid:4486503 |
| AUSTRIAN R and ROSENBLUM R | The relative efficacy of erythromycin (ilotycin) and of penicillin in the treatment of pneumococcal lobar pneumonia. | 1953 | Am. J. Med. Sci. | pmid:13104398 |
| Simon HJ | Antimicrobial susceptibility of group D hemolytic streptococci (enterococci). | 1967 | Am. J. Med. Sci. | pmid:5180810 |
| BLOUGH HA et al. | Serum levels and clinical results with erythromycin propionate. | 1960 | Am. J. Med. Sci. | pmid:13801645 |
| CICCANTELLI MJ and GARRY MW | Erythromycin: an evaluation for clinical toxicity. | 1956 | Am. J. Med. Sci. | pmid:13362260 |
| ROBINSON MM | Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate. | 1962 | Am. J. Med. Sci. | pmid:14492926 |
| Devasia RA et al. | Compliance with azithromycin versus erythromycin in the setting of a pertussis outbreak. | 2009 | Am. J. Med. Sci. | pmid:19301451 |
| Williams ME et al. | Legionnaires' disease with acute renal failure. | 1980 May-Jun | Am. J. Med. Sci. | pmid:7424965 |
| Toala P et al. | Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences. | 1969 | Am. J. Med. Sci. | pmid:4984452 |
| HIRSCH HA and FINLAND M | Effect of food on the absorption of erythromycin propionate, erythromycin stearate and triacetyloleandomycin. | 1959 | Am. J. Med. Sci. | pmid:13661157 |
| Holoshitz J et al. | Listeria monocytogenes pericarditis in a chronically hemodialyzed patient. | 1984 Jul-Aug | Am. J. Med. Sci. | pmid:6465192 |
| Feigin RD et al. | Treatment of penicillin-resistant staphylococcal infections with clindamycin. | 1971 | Am. J. Med. Sci. | pmid:5578775 |
| GRIFFITH RS and BLACK HR | COMPARISON OF THE BLOOD LEVELS OBTAINED AFTER SINGLE AND MULTIPLE DOSES OF ERYTHROMYCIN ESTOLATE AND ERYTHROMYCIN STEARATE. | 1964 | Am. J. Med. Sci. | pmid:14106882 |
| RodrÃguez-Gutiérrez R et al. | Herpes zoster ophthalmicus masked by hymenoptera stings. | 2014 | Am. J. Med. Sci. | pmid:23085675 |
| HIRSCH HA et al. | Effect of food on absorption of a new form of erythromycin propionate. | 1960 | Am. J. Med. Sci. | pmid:14401969 |
| McGehee RF et al. | Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. | 1968 | Am. J. Med. Sci. | pmid:4386950 |
| Oppenheimer S and Turek M | Laboratory and clinical evaluation of 7-chloro-7-deoxylincomycin. | 1968 | Am. J. Med. Sci. | pmid:4386951 |
| CLAPPER WE et al. | THE SUSCEPTIBILITY OF CERTAIN BACTERIA TO LINCOMYCIN AS RELATED TO ATTAINABLE SERUM LEVELS IN HUMAN ADULTS. | 1964 | Am. J. Med. Sci. | pmid:14130319 |
| FISCHER HW and HOAK JC | MIMICRY OF ACUTE CHOLECYSTITIS BY ERYTHROMYCIN ESTOLATE REACTIONS. REPORT OF 2 CASES. | 1964 | Am. J. Med. Sci. | pmid:14130320 |
| McCabe WR and Lorian V | Comparison of the antibacterial activity of rifampicin and other antibiotics. | 1968 | Am. J. Med. Sci. | pmid:4387027 |
| Martinez JA et al. | Diffuse panbronchiolitis in Latin America. | 2000 | Am. J. Med. Sci. | pmid:10746829 |
| Baird IM et al. | Case report. Clinical manifestations and treatment of Legionnaires' disease. | 1979 Mar-Apr | Am. J. Med. Sci. | pmid:463949 |
| Gray BM | Case report: Rhodococcus equi pneumonia in a patient infected by the human immunodeficiency virus. | 1992 | Am. J. Med. Sci. | pmid:1595781 |
| Nattel S et al. | Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism. | 1990 | Am. J. Med. | pmid:2382671 |
| Klein JO | Emerging perspectives in management and prevention of infections of the respiratory tract in infants and children. | 1985 | Am. J. Med. | pmid:4014286 |
| Rudin JE et al. | Failure of erythromycin in treatment of Legionella micdadei pneumonia. | 1984 | Am. J. Med. | pmid:6607673 |
| Diehl AM et al. | Cholestatic hepatitis from erythromycin ethylsuccinate. Report of two cases. | 1984 | Am. J. Med. | pmid:6609640 |
| Tablan OC and Reyes MP | Chronic interstitial pulmonary fibrosis following Mycoplasma pneumoniae pneumonia. | 1985 | Am. J. Med. | pmid:4025379 |
| Swanson DJ et al. | Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia. | 1992 | Am. J. Med. | pmid:1731511 |
| Bolton WK et al. | Ventriculojugular shunt nephritis with Corynebacterium bovis. Successful therapy with antibiotics. | 1975 | Am. J. Med. | pmid:1163549 |
| Stocks JM et al. | Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin. | 1989 | Am. J. Med. | pmid:2690620 |
| Bowler WA et al. | Gastrointestinal side effects of intravenous erythromycin: incidence and reduction with prolonged infusion time and glycopyrrolate pretreatment. | 1992 | Am. J. Med. | pmid:1546723 |